Skip to main content

Aardvark Therapeutics, Inc.

AARD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001774857

In the last 90 days, Aardvark Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 71 institutions reported holding it in 13F filings for Q2 2026, worth $54.3M in total; no superinvestor holds it.

13F holders, Q3 2025

Institutional positions in Aardvark Therapeutics, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
49
+14 vs. Q2 2025
Shares held
9.46M
+545.2K (+6.1%) vs. Q2 2025
Total value
$125.7M
+$5.20M (+4.3%) vs. Q2 2025
New holders
15
20 more added
Sold out
1
7 more reduced

Compare with Q2 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting AARD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2025: 49 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 0 institutionsQ2 2022: 0 institutionsQ3 2022: 0 institutionsQ4 2022: 0 institutionsQ1 2023: 0 institutionsQ2 2023: 0 institutionsQ3 2023: 0 institutionsQ4 2023: 0 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 27 institutionsQ2 2025: 35 institutionsQ3 2025: 49 institutionsQ4 2025: 66 institutionsQ1 2026: 79 institutionsQ2 2026: 71 institutions
Value heldQ3 2025: $125.7M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $0Q2 2022: $0Q3 2022: $0Q4 2022: $0Q1 2023: $0Q2 2023: $0Q3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $65.1MQ2 2025: $120.5MQ3 2025: $125.7MQ4 2025: $141.0MQ1 2026: $38.5MQ2 2026: $54.3M
Institutions holding AARD and their total value by quarter
QuarterHoldersValue
Q2 202671$54.3M
Q1 202679$38.5M
Q4 202566$141.0M
Q3 202549$125.7M
Q2 202535$120.5M
Q1 202527$65.1M
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 20230$0
Q3 20230$0
Q2 20230$0
Q1 20230$0
Q4 20220$0
Q3 20220$0
Q2 20220$0
Q1 20220$0
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q3 2025

Shares, value and share of portfolio for each institution holding Aardvark Therapeutics, Inc.; share changes are against Q2 2025.

Institutions holding AARD in Q3 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Decheng Capital LLC3,917,299$52.1M9.08%00.0%Unchanged
Citadel Advisors LLC1,359,883$18.1M0.01%+76,151+5.9%Added
Laurion Capital Management LP1,049,721$14.0M1.90%+60,653+6.1%Added
Vanguard Group Inc555,721$7.39M0.00%+94,744+20.6%Added
Adage Capital Partners GP, L.L.C.350,000$4.65M0.01%+175,000+100.0%Added
Millennium Management LLC319,623$4.25M0.00%+319,623New
BlackRock, Inc.309,465$4.11M0.00%+103,670+50.4%Added
Silverarc Capital Management, LLC306,912$4.08M0.59%+20,105+7.0%Added
Schonfeld Strategic Advisors LLC253,752$3.37M0.02%−25,506−9.1%Reduced
Geode Capital Management, LLC194,035$2.58M0.00%+57,108+41.7%Added
Cresset Asset Management, LLC141,783$1.88M0.01%+141,783New
Cantor Fitzgerald, L. P.96,682$1.28M0.03%+20,000+26.1%Added
State Street Corp93,005$1.24M0.00%+55,693+149.3%Added
Morgan Stanley68,462$909.9K0.00%+59,502+664.1%Added
Two Sigma Investments, LP63,569$844.8K0.00%+63,569New
Northern Trust Corp57,197$760.1K0.00%+12,112+26.9%Added
BNP Paribas Arbitrage, SA56,546$751.5K0.00%+21,052+59.3%Added
UBS Group AG54,728$727.3K0.00%+2,804+5.4%Added
Barclays PLC39,926$530.6K0.00%−10,632−21.0%Reduced
Two Sigma Advisers, LP25,700$341.6K0.00%+25,700New
Bank of America Corp23,930$318.0K0.00%+15,941+199.5%Added
Bridgeway Capital Management, LLC22,000$292.4K0.01%+22,000New
Jane Street Group, LLC19,447$258.5K0.00%+19,447New
Goldman Sachs Group Inc18,927$251.5K0.00%+332+1.8%Added
Bank of New York Mellon Corp15,523$206.3K0.00%+15,523New
Charles Schwab Investment Management Inc14,240$189.3K0.00%00.0%Unchanged
Deutsche Bank AG5,725$76.1K0.00%00.0%Unchanged
Rhumbline Advisers5,705$75.8K0.00%+216+3.9%Added
Wells Fargo & Company3,917$52.1K0.00%+678+20.9%Added
New York State Common Retirement Fund3,823$50.8K0.00%−3,477−47.6%Reduced
Mirae Asset Global ETFs Holdings Ltd.2,585$34.4K0.00%−506−16.4%Reduced
JPMorgan Chase & Co2,316$30.8K0.00%−361−13.5%Reduced
Police & Firemen's Retirement System of New Jersey2,120$28.2K0.00%+2,120New
Tower Research Capital LLC (TRC)1,185$15.7K0.00%−83−6.5%Reduced
STRS Ohio1,100$14.6K0.00%00.0%Unchanged
Stone House Investment Management, LLC1,000$13.3K0.00%+1,000New
Legal & General Group Plc587$7.80K0.00%00.0%Unchanged
Ameritas Investment Partners, Inc.578$7.68K0.00%00.0%Unchanged
Russell Investments Group, Ltd.469$6.23K0.00%+469New
FMR LLC363$4.82K0.00%+363New
California State Teachers Retirement System355$4.72K0.00%+1+0.3%Added
Royal Bank of Canada305$4.00K0.00%+37+13.8%Added
Amalgamated Bank193$3.00K0.00%00.0%Unchanged
Sterling Capital Management LLC182$2.42K0.00%+107+142.7%Added
Citigroup Inc167$2.22K0.00%−1,795−91.5%Reduced
The PNC Financial Services Group, Inc.140$1.86K0.00%+140New
EverSource Wealth Advisors, LLC60$7970.00%+60New
SRS Capital Advisors, Inc.21$2800.00%+21New
CWM, LLC15$00.00%+15New
Cormorant Asset Management, LP0$00.00%−800,189−100.0%Sold out